Chester Springs, PA, United States of America

Gerard M McGeehan


Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gerard M McGeehan

Introduction

Gerard M McGeehan is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. With a total of 6 patents, McGeehan's work has had a substantial impact on medical treatments.

Latest Patents

Among his latest patents is a groundbreaking invention related to the therapeutic uses of tri-aryl acid derivatives. This patent focuses on the use of triaryl acid derivatives of a specific formula and their pharmaceutical compositions as PPAR ligand receptor binders. These PPAR ligand receptor binders are valuable as agonists or antagonists of the PPAR receptor. Additionally, he has developed PPAR-γ agonists as agents for the treatment of type II diabetes, showcasing his commitment to addressing critical health issues.

Career Highlights

Throughout his career, McGeehan has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Deutschland GmbH and Lexicon Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in drug development.

Collaborations

McGeehan has collaborated with esteemed colleagues such as Zaid Jayyosi and Michael F Kelley. These partnerships have further enhanced his research and development efforts, leading to advancements in therapeutic applications.

Conclusion

Gerard M McGeehan's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…